Akoya Biosciences, Inc.
AKYA
$1.09
-$0.015-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.37M | -57.97M | -60.35M | -68.01M | -63.32M |
| Total Depreciation and Amortization | 7.65M | 7.91M | 8.66M | 8.82M | 8.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.49M | 18.84M | 21.35M | 23.46M | 18.01M |
| Change in Net Operating Assets | -13.89M | -15.48M | -20.86M | -16.24M | -14.48M |
| Cash from Operations | -44.10M | -46.71M | -51.20M | -51.97M | -50.90M |
| Capital Expenditure | -2.46M | -2.01M | -2.41M | -3.66M | -3.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.60M | -25.33M | -38.78M | -48.01M | 7.00M |
| Cash from Investing | -24.05M | -27.34M | -41.19M | -51.67M | 3.35M |
| Total Debt Issued | -- | 11.25M | 11.25M | 11.25M | 11.25M |
| Total Debt Repaid | -1.02M | -700.00K | -709.00K | -709.00K | -676.00K |
| Issuance of Common Stock | 91.00K | 82.00K | 100.00K | 48.29M | 48.31M |
| Repurchase of Common Stock | -214.00K | -214.00K | -214.00K | -149.00K | -94.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.06M | -2.06M | -2.06M | -1.86M | -1.95M |
| Cash from Financing | -3.21M | 8.36M | 8.37M | 56.82M | 56.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.36M | -65.69M | -84.02M | -46.81M | 9.29M |